Cristián Hernández

With more than two decades of experience in investment and development of biotech companies, Cristián has been CEO, Director of Companies and Research Centers, such as Fundación Ciencia & Vida, Nova Mineralis, Ingalfarma, Phage Labs, among others.

Pablo Fernández

With over a decade of experience working in startup development, Pablo is a Director of the Alerce Fund and a board member of Andes Ag, GeneproDX, Done Properly, Polynatural, among other companies.

Roberto Loehnert

With more than twenty years of experience in investment and development of alternative assets, Roberto is co-founder of Venturance Investments and member of the board of directors of Clínica Alemana de Santiago, Bbosch, Lippi and Streat Burger, among others.

Bernardita Méndez

Bernardita has more than thirty years of experience in regulatory affairs and intellectual property in biomedical companies. She is president and co-founder of Fundación Ciencia y Vida. She also serves on the boards of Fundación Chile, Universidad Andrés Bello, Comunidad Mujer and other organizations.

Pablo Valenzuela

After more than four decades of investment and business development in the biotechnology industry, Pablo has developed many cutting-edge medical technologies, such as the hepatitis B vaccine. He co-founded Chiron Corporation in 1982, one of the industry’s early pioneers in genetic engineering. In 2005, his company was acquired by Novartis for $8.9 billion.